ChemicalBook >> CAS DataBase List >>HVRLZEKDTUEKQH-NEGCSKJWSA-N

HVRLZEKDTUEKQH-NEGCSKJWSA-N

CAS No.
1331635-21-2
Chemical Name:
HVRLZEKDTUEKQH-NEGCSKJWSA-N
Synonyms
HVRLZEKDTUEKQH-NEGCSKJWSA-N;[2H3]- Olopatadine Hydrochloride;2-[(11Z)-11-[3-[methyl(trideuteriomethyl)amino]propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid
CBNumber:
CB33564603
Molecular Formula:
C21H21ClD3NO3
Molecular Weight:
376.891645334
MDL Number:
MOL File:
1331635-21-2.mol
Last updated:2023-06-08 09:03:02

HVRLZEKDTUEKQH-NEGCSKJWSA-N Properties

storage temp. Store at -20°C
solubility Methanol: Slightly soluble,
form A solid
Water Solubility Water: Slightly soluble

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictograms
GHS06,GHS09
Signal word  Danger
NFPA 704
0
2 0

HVRLZEKDTUEKQH-NEGCSKJWSA-N price More Price(1)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TRC O575002 Olopatadine-d3Hydrochloride 1331635-21-2 1mg $175 2021-12-16 Buy
Product number Packaging Price Buy
O575002 1mg $175 Buy

HVRLZEKDTUEKQH-NEGCSKJWSA-N Chemical Properties,Uses,Production

Uses

Labelled Olopatadine. Dual acting histamine H1-receptor antagonist and mast cell stabilizer. Antiallergic; antihistaminic.

Biological Activity

Olopatadine-d3 is intended for use as an internal standard for the quantification of olopatadine by GC- or LC-MS. Olopatadine is a histamine H1 receptor antagonist (Ki =41 nM).1 It is 1,059- and 4,177-fold selective for histamine H1 over H2 and H3 receptors, respectively. Olopatadine inhibits histamine-induced phosphoinositide turnover in isolated human conjunctival epithelial cells, isolated human corneal fibroblasts, and human trabecular meshwork (TM3) cells (IC50s = 9.5, 19, and 39.9 nM, respectively). In vivo, olopatadine inhibits passive cutaneous anaphylaxis in rats (ED50 = 49 μg/kg) and IgG1-mediated bronchoconstriction in ovalbumin-sensitized guinea pigs (ED50 = 30 μg/kg).2 Formulations containing olopatadine have been used in the treatment of allergic rhinitis and conjunctivitis, as well as in the treatment of itch in patients with well-controlled urticaria.

References

1.Sharif, N.A., Xu, S.X., and Yanni, J.M.Olopatadine (AL-4943A): Ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitisJ. Ocul. Pharmacol. Ther.12(4)401-407(1996) 2.Ohshima, E., Otaki, S., Sato, H., et al.Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivativesJ. Med. Chem.35(11)2074-2084(1992)

HVRLZEKDTUEKQH-NEGCSKJWSA-N Preparation Products And Raw materials

Raw materials

Preparation Products

HVRLZEKDTUEKQH-NEGCSKJWSA-N Suppliers

Global( 8)Suppliers
Supplier Tel Email Country ProdList Advantage
Energy Chemical 021-58432009 400-005-6266 marketing1@energy-chemical.com China 44806 58
Changzhou Xianglong Pharmaceutical Technology Co., LTD 18661161657 yaoxiangqiu2021@163.com China 9996 58
ChemeGen 中国 18818260767 2625930290@qq.com China 6973 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11974 58
Nanjing Shizhou Biology Technology Co.,Ltd 17301488900 judy.xia@synzest.com China 12582 58
HVRLZEKDTUEKQH-NEGCSKJWSA-N [2H3]- Olopatadine Hydrochloride 2-[(11Z)-11-[3-[methyl(trideuteriomethyl)amino]propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid 1331635-21-2